NATIONAL FRAMEWORK AGREEMENT FOR THE SUPPLY OF HUMAN NORMAL IMMUNOGLOBULIN AND ANTI-D IMMUNOGLOBULIN
Hull University Teaching Hospitals NHS TrustcontractContracts Finder ↗Ref HEY/21/390SME suitablecomplete
Estimated value
£189k
Awarded value
£189k
Awarded 27 Jun 2021
Suppliers
1
Lots
1
1 awarded
Published
08 Sept 2021
Deadline 01 Jun 2021
Description
This is a publication to Award a Contract to BIO PRODUCTS LABORATORY and CSL BEHRING (UK) LIMITED for the Hull University Teaching Hospital to Access the products of Human Normal Immunoglobulin and Anti-D Immunoglobulin utilising the NHS England Commercial Medicines Unit (CMU) National Framework Agreement for Human Normal Immunoglobulin and Anti-D Immunoglobulin - Reference Number: CM/PMS/17/5550.
Scope
- Reference
- HEY/21/390
- Total value
- £188,608 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2021 to 29 Jun 2023
- CPV classifications
- 33141510 33141630 33651520
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 01 Jun 2021, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£189k
Award date
27 Jun 2021
Contract start
30 Jun 2021
Contract end
29 Jun 2023